Founded
Established
Launch of pregnancy diagnostic reagent "Gonastick 25"
Launch of antiviral cream "Arasena-A Cream 3%"
Ota-Hara Factory ISO 14001 Certification Obtained
Launch of health and beauty supplement "Vitacolage"
Launch of G n R H derivative formulation "Sprayquar"
Start of sales for Mochida Medical Systems Co., Ltd. (medical device division spun off)
Launch of hemostatic agent "Thrombine Liquid Motida Soft Bottle"
Launch of basic cosmetics "Collage S Cosmetic Series"
Start of sales for Mochida Healthcare Co., Ltd. (healthcare division spun off)
Start of sales for Mochida Siemens Medical Systems Co., Ltd.
Launch of EPA formulation "Epadeal S900" stick packaging
Mochida Pharmaceutical Factory Co., Ltd. Commences Operations
Results of large-scale trial "JELIS" of "Epadeal" announced by the American Heart Association (AHA)
First Japanese sensitive skin whitening series "Collage Whitening Series" released
"Collage Full Full Liquid Soap" released
First Japanese condyloma acuminatum treatment drug "Besselna" released
Joint promotion of antihypertensive drug "Diovan" started (ended December 2008)
Uterine fibroid treatment drug "Dinagest" released
Enzyme-infused powdered cleanser "Collage White Peel" launch
Transdermal estradiol formulation "Divigel" launch
Antifungal shampoo and conditioner "Collage Full Full Next" launch
Pregnancy diagnostic aid reagent "Gonastick W" launch
Antidepressant "Lexapro" launch
Rapid-acting postprandial glucose-lowering agent "Fastick" launch
Specific health food (Tokho) "Glucorina" launch
Switch OTC drug "Epadeal" launch
"Collage B.K.AGE Series" launch
Biologic similar "Filgrastim BS "Motida"" launch
Chronic pain/after-extraction pain treatment drug "Tramset" tablet launch
Mochida Pharmaceutical Sales Co., Ltd. Commences Operations
Hypertension treatment drug "Ateedio" tablet launch
"Collage Cosmetics Series" renewal launch
Pulmonary arterial hypertension treatment drug "Treprostol" launch
Ulcerative colitis treatment drug "Realda" launch
Extracorporeal diagnostic drug for ulcerative colitis "Carprotection Motida" launch
Antineoplastic agent "Doxil" launch
Chronic constipation treatment drug "Gufis" launch
Biologic similar "Etanercept BS "MA"" launch
"Collage Full Full Premium Shampoo" launch
Release of chronic constipation treatment drug "Mobicol"
Release of "Collage Repair Series"
Release of biosimilar "Teriparatide BS "Motida"
Release of pregnancy diagnostic aid reagent "Gonacard W"
Release of gout and hyperuricemia treatment drug "Yuris"
Release of dysmenorrhea treatment drug "Dinagest tablets 0.5 mg"
Release of biosimilar "Adalimumab BS "MA"
Transition to Tokyo Stock Exchange Prime Market
Completion and commencement of operations at new headquarters building (Yotsuya)
Release of self-emulsifying high-purity EPA formulation "Epadeal EM"
Release of ulcerative colitis treatment drugs "Onbo" and "Colichment"
Release of biosimilar "Pegfilgrastim BS subcutaneous injection "Motida"
Neural Regeneration Inducing Material "ReFeel" Released (USA)
Mochida Medical USA, Inc. Commences Operations
Release of cartilage repair material "Motijel"
Release of high-purity EPA formulation "Eicosapentaenoic acid ethyl granule capsule "Motida"
Release of "Collage Full Full Plus Series"